Elsevier Launches New Journal: Journal of Obsessive-Compulsive and Related Disorders
An international forum for communication and collaboration across clinical and academic fields concerned with obsessive-compulsive disorders
Oxford, March 27, 2012 – Elsevier, a world-leading provider of scientific, technical and medical information products and solutions, is pleased to announce the launch of a new quarterly journal, Journal of Obsessive-Compulsive and Related Disorders. The first issue of the journal is now available online.
Obsessive-compulsivedisorders (OCD) have intrigued those in the medical and mental health fields for as long as the disorders were first identified by Freud over a century ago. Although crucial advances in understanding and treating OCD have been made over the past half century, important questions remain unanswered regarding the causes of OCD, its true nature, and its boundaries with other seemingly similar mental disorders. Examples are that OCD in elderly and the very young are not well understood, nor do we know how they are influenced by ethnic and cultural factors or how these disorders can be prevented? How can we improve on existing treatments? These and other issues are addressed in the Journal of Obsessive-Compulsive and Related Disorders.
Prof. Jonathan S. Abramowitz of University of North Carolina at Chapel Hill, Editor-in-Chief of the journal said of the launch, “As the founding Editor‐in‐Chief of Journal of Obsessive-Compulsive and Related Disorders,my vision for the journal is to create an international and interdisciplinary forum to foster communication and collaboration across the various clinical and academic fields concerned with Obsessive-compulsive disorders (OCD).”
The Journal of Obsessive-Compulsive and Related Disorders publishes high quality research and clinically-oriented articles dealing with all aspects of obsessive-compulsive disorders (OCD) and related conditions (obsessive-compulsive spectrum disorders: e.g. trichotillomania, hoarding, body dysmorphic disorder).
The first issue is now freely available to view online on SciVerse ScienceDirect.
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Research Intelligence and ClinicalKey— and publishes over 2,500 journals, including The Lancet and Cell, and more than 35,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group, a world-leading provider of information and analytics for professional and business customers across industries. www.elsevier.com
+ 44 1865 843825